Unum Therapeutics
Why Robinhood?
You can watch UMRX and buy or sell other stocks, ETFs, and their options commission-free!About UMRX
Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation and other mutations in KIT exon 17.
UMRX Key Statistics
Stock Snapshot
As of today, Unum Therapeutics(UMRX) shares are valued at $9.40. The company's market cap stands at 1.61B, with a P/E ratio of -15.63.
Unum Therapeutics(UMRX) stock opened on 2026-07-06 at —. The price climbed to — and dipped to —.
The Unum Therapeutics(UMRX)'s current trading volume is 0, compared to an average daily volume of 4.12M.
During the past year, Unum Therapeutics(UMRX) stock moved between $9.13 at its lowest and $43.73 at its peak.
During the past year, Unum Therapeutics(UMRX) stock moved between $9.13 at its lowest and $43.73 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.